Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoproliferative Disorders 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Filgrastim 8Cyclophosphamide 8Cyclosporine 7fludarabine phosphate 6Antilymphocyte Serum 6Rituximab 5Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Methotrexate 5Cord Blood Stem Cell Transplantation 5Etoposide 4Busulfan 4Whole-Body Irradiation 3Methylprednisolone 3Melphalan 3Vincristine 2Tacrolimus 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Doxorubicin 2Cytarabine 2Carboplatin 2Amplified Fragment Length Polymorphism Analysis 2venetoclax 1pegfilgrastim 1obatoclax 1ibritumomab tiuxetan 1fludarabine 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Dendritic Cell Sarcoma, Interdigitating × beta-Glucans × Clear all
NCT00087009 2013-03-19

Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation

Memorial Sloan Kettering Cancer Center

Phase 1 Terminated
3 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoproliferative Disorders, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡